Guillaume Couillard

Guillaume Couillard

government official Canada

Guillaume Couillard is the Director General of the Patented Medicine Prices Review Board (PMPRB) in Canada. He plays a pivotal role in overseeing the regulatory framework that monitors and evaluates pharmaceutical pricing in the Canadian market. With a focus on transparency and efficiency, Couillard has been instrumental in implementing new guidelines that streamline the process of drug price assessment, aiming to protect Canadian consumers from excessive pricing while encouraging innovation in the pharmaceutical industry.

Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
0
Power
0$
Sentiment
0.00
Countries Mentioned

No country-level mention data available.

Interactive World Map

Each country's color is based on "Mentions" from the table above.

Recent Mentions

Canada Canada: Guillaume Couillard, director general of the PMPRB, said the purpose of the new guidelines is to be transparent to the industry on how the regulator will operate. 7

The Globe and Mail: Federal drug-price regulator unveils new guidelines for 2026